We therefore hypothesized that LST1-mediated efferocytosis forms an immunological bridge, connecting the chronic inflammatory milieu of T2DM to the immunosuppressive tumor microenvironment of ccRCC. The gene discussed is LST1; the disease is type 2 diabetes mellitus.